Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Individually Tailored Balance Training for Older Adults at Risk of Falling (STABLERCT)

14 novembre 2026 aggiornato da: Kasper Søndergaard, Copenhagen University Hospital at Herlev

Specific Training According to BaLance Evaluation (STABLE) Versus the Otago Exercise Program for Older Adults With Impaired Balance in Cross-sectoral Rehabilitation: A Double-blind Randomized Controlled Trial

The goal of this clinical trial is to learn whether individually tailored balance training based on the STABLE approach (Specific Training According to BaLance Evaluation) prevents falls better than the Otago Exercise Program in older adults with impaired balance. STABLE uses five simple clinical tests to build a balance profile, from which a physical therapist selects a few home exercises aimed at the person's main balance problems. The main question it aims to answer is: Does STABLE reduce the proportion of participants who fall at least once during the 26 weeks after the training period, compared with the Otago Exercise Program? Researchers will also compare number of falls, injurious falls, hospital admissions, mortality, balance and gait performance, fear of falling, dizziness, physical activity and quality of life.

Participants will:

  • be randomized to STABLE or to the Otago Exercise Program (supplemented with gaze stabilization exercises if they have vestibular dysfunction)
  • perform supervised home exercises for 3 to 4 months with 2 to 6 follow-up physical therapy consultations at the hospital or in their municipal rehabilitation center
  • complete a balance and gait test before and after the training period, measured with a body-worn movement sensor and a force plate
  • answer a short text message (SMS) questionnaire about falls once a week for 26 weeks after the training period Hospital admissions and mortality are collected from medical records 6 and again 24 months after the end of training. Participants' and physical therapists' experiences of the two approaches are explored in qualitative interviews.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Falls among older adults are common and costly, and exercise, including balance training, reduces the rate of falls, but existing programs have shown only small reductions in the number of people who fall. The Otago Exercise Program (OEP) is the most widely used home-based falls prevention program, but it is only partly tailored to the individual. STABLE is a new approach in which five clinical tests, each measuring a specific balance domain (limits of stability, sensory orientation, reactive stepping, power and turning), form a balance profile that guides the choice of a few targeted home exercises. In a cohort study, 40% fewer patients fell within six months after STABLE-based rehabilitation, but STABLE has not been tested in a controlled trial.

This is a double-blind (participant and outcome assessor), two-arm, parallel-group randomized controlled trial with 1:1 allocation. Over two years, 552 older adults referred for physical therapy assessment of balance at Herlev and Gentofte Hospital or Rigshospitalet, Denmark, are included. Randomization is stratified by the including physical therapist, history of falls before inclusion and planned follow-up setting (hospital or municipality), using randomly permuted blocks of 4 and 6, and is performed automatically in REDCap. Participants receive 3 to 4 months of supervised home exercise according to allocation, followed up at the hospital or in participating municipal rehabilitation centers. A blinded tester measures gait (inertial sensor), standing balance, sit-to-stand power and reach (force plate) and patient-reported outcomes before and after the intervention. Falls are recorded with a weekly SMS questionnaire for 26 weeks after the end-of-treatment test; hospital admissions and mortality are collected from medical records at 6 and 24 months. The primary outcome is the proportion of participants who fall at least once during the 26 weeks, analyzed by intention to treat with multiple imputation. A qualitative study explores participants' and physical therapists' experiences.

Tipo di studio

Interventistico

Iscrizione (Stimato)

552

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

      • Herlev, Danimarca, 2730
        • Genoptræning og Forebyggelse, Herlev Kommune
        • Contatto:
      • Rødovre Municipality, Danimarca, 2610
        • Genoptræning, Rødovre Kommune
        • Contatto:
          • Henriette W Bjerrum, BSc
          • Numero di telefono: 004520418153
          • Email: cn26232@rk.dk
      • Ølstykke, Danimarca, 3650
        • Sundhed og omsorg, Egedal kommune
        • Contatto:
    • Region Sjælland
      • Copenhagen, Region Sjælland, Danimarca, 2100
        • Copenhagen University Hospital - Rigshospitalet
        • Contatto:
        • Contatto:
        • Sub-investigatore:
          • Stefania Serafin, Professor
      • Hellerup, Region Sjælland, Danimarca, 2900
        • Copenhagen University Hospital - Herlev and Gentofte Hospital
        • Contatto:
        • Contatto:
        • Investigatore principale:
          • Kasper Søndergaard, PhD
        • Sub-investigatore:
          • Carsten B Juhl, Professor
        • Sub-investigatore:
          • Anders M Vinther, PhD
        • Sub-investigatore:
          • Jesper Ryg, Professor

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

65 anni e precedenti (Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Referred to physical therapy assessment of balance at Herlev and Gentofte Hospital or Rigshospitalet
  • Aged 65 years or older
  • Impaired balance at the physical therapy assessment
  • Judged able to carry out home-based self-training
  • Living in a participating municipality (Rødovre, Herlev or Egedal), or, if living elsewhere, judged by the physical therapist to be best rehabilitated with follow-up at the hospital

Exclusion Criteria:

  • Significant cognitive or language limitations preventing self-training or informed consent
  • Declines rehabilitation or participation in the study
  • No balance problems at the physical therapy assessment

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: STABLE

Individually tailored home exercise based on the STABLE approach. Exercises are selected from the five STABLE test scores, the patient's goals and overall health condition, typically targeting the primary balance limitations at an appropriate level of difficulty. 3 to 4 months of home exercise with 2 to 6 follow-up physical therapy consultations in which exercises are adjusted.

Specific Training According to BaLance Evaluation (STABLE) is centered on five clinical tests (Maximal reach test [Meach], Test of Reference frame Interaction in Balance [TRIB], Reactive Four Square Step Test [RFSST], Adjusted Sit To Stand test [ASTS], Turn And Touch test [TAT]) measuring five balance domains (limits of stability, sensory orientation, reactive stepping, power, turning) form a balance profile used together with the patient's goals and health condition to select a few targeted home exercises (https://godbalance.dk/). Instructed by a physical therapist at the hospital and followed up at the hospital or in the municipal rehabilitation center for 3 to 4 months.

Altri nomi:
  • Specific Training According to Balance Evaluation
Comparatore attivo: Otago Exercise Program

Home exercise according to the Otago Exercise Program. The level is chosen from the 30-second chair stand test and the 4-Stage Balance Test. Participants with vestibular dysfunction are also instructed in gaze stabilization exercises (GSE). Same number and schedule of follow-up consultations as the STABLE arm.

Otago Exercise Program (OEP) is a standardized home-based strength and balance program (https://www.livestronger.org.nz/assets/Uploads/acc1162-otago-exercise-manual.pdf). Level chosen from the 30-second chair stand test and the 4-Stage Balance Test. Participants with vestibular dysfunction additionally receive gaze stabilization exercises. Same delivery and follow-up as the STABLE arm.

Altri nomi:
  • OEP
  • Vestibular rehabilitation exercises

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Proportion of participants who fall at least once
Lasso di tempo: Weekly for 26 weeks after the end-of-treatment test (approximately 3 to 5 months after baseline)

A fall is defined as an unexpected event in which the participant comes to rest on the ground, floor or lower level, regardless of cause or consequence. Recorded with a weekly SMS questionnaire ("Have you fallen since you last answered this questionnaire?"). Each answer covers all weeks from the previous answer. A fall-related hospital admission in the medical record also counts as a fall. Participants are classified as non-fallers only if all answers are "no", week 26 is answered and no fall-related admission is recorded. Others with incomplete data are imputed. The test SMS sent at the end-of-treatment test does not count. Participants who cannot receive SMS report falls via a relative's phone, or via a paper fall diary returned by post supplemented by a telephone call at 6 months.

Weekly for 26 weeks after the end-of-treatment test (approximately 3 to 5 months after baseline)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Number of falls
Lasso di tempo: 26 weeks after the end-of-treatment test

Total number of falls reported in the weekly SMS (1 to 10, or more than 10, per answer), at least the number of fall-related admissions in the medical record, analyzed as a rate per week covered.

26 weeks after the end-of-treatment test
Number of falls with loss of consciousness
Lasso di tempo: 26 weeks after the end-of-treatment test

Self-reported in the weekly SMS questionnaire (reason for falling).

26 weeks after the end-of-treatment test
Number of falls with fracture
Lasso di tempo: 26 weeks after the end-of-treatment test

Self-reported in the weekly SMS questionnaire.

26 weeks after the end-of-treatment test
Hospital admissions
Lasso di tempo: 6 and 24 months after the end-of-treatment test

Number of all-cause and fall-related hospital admissions, from medical records.

6 and 24 months after the end-of-treatment test
Mortality
Lasso di tempo: 6 and 24 months after the end-of-treatment test

Vital status and date of death, from medical records.

6 and 24 months after the end-of-treatment test
Rehabilitation courses
Lasso di tempo: 6 and 24 months after the end-of-treatment test

Number of subsequent rehabilitation courses, from medical records.

6 and 24 months after the end-of-treatment test
Gait performance and movement quality
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Seven walking tasks measured with an inertial sensor (Cometa WaveTrack) on the lower back: Timed Up and Go, 3-meter walk, line walking, foam walking with eyes open and closed, figure-of-eight walk and walking over an obstacle. Outcomes: task duration (s), log dimensionless jerk (LDLJ-A), spectral arc length (SPARC), root mean square acceleration (anteroposterior, mediolateral, vertical) and turning velocity. Fastest trial of two per task.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Postural sway
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Modified Clinical Test of Sensory Interaction on Balance (firm and foam surface, eyes open and closed, 40 s each) on a force plate (AMTI AccuSway). Centre of pressure (COP) sway measures (e.g. RMS, velocity, sway area) from the middle 30 s, and loss of balance.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Sit-to-stand power
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Peak power during a fast sit-to-stand on the force plate (body weight × vertical displacement / time). Best of 2 trials.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Forward reach (limits of stability)
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Maximal anterior COP displacement during forward reach on the force plate, expressed as a percentage of the distance from the posterior edge of the medial malleolus to the tip of the big toe. Best of 2 trials.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
STABLE test scores
Lasso di tempo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Scores on the five STABLE tests (Mreach, TRIB, RFSST, ASTS, TAT). Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
Dynamic Gait Index (DGI)
Lasso di tempo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Score 0 to 24, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
4-Stage Balance Test (FSB)
Lasso di tempo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Score 0 to 40, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
30-second chair stand test (30STS)
Lasso di tempo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Score 0 and above, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
Fear of falling
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Falls Efficacy Scale-International (FES-I), 16 to 64, higher is more concern.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Dizziness handicap
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Dizziness Handicap Inventory (DHI), 0 to 100, higher is more handicap.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Physical activity
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

Physical Activity Scale for the Elderly (PASE).

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Health-related quality of life
Lasso di tempo: Baseline and end of treatment (approximately 3 to 5 months after baseline)

EQ-5D-5L index and EQ VAS.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Patient-reported global change and tailoring
Lasso di tempo: End of treatment (approximately 3 to 5 months after baseline)

Perceived overall change in balance and/or dizziness, perceived tailoring of home exercises and continuity between assessment and exercises (5-point scales).

End of treatment (approximately 3 to 5 months after baseline)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Physical therapists' use of test results
Lasso di tempo: Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)

Questions answered by the municipal physical therapist at the final assessment of each participant: "Did you use the test results to select or adjust exercises?" (5-point Likert scale).

Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
Exercise adherence
Lasso di tempo: Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)

Self-reported adherence to home exercise (4-point scale), number of exercise sessions per week and duration.

Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
Adverse effects during exercise
Lasso di tempo: End of treatment (approximately 3 to 5 months after baseline)

Frequency, intensity and duration of pain and dizziness during home exercise, falls during exercise, and worsening or new health problems during the training period

End of treatment (approximately 3 to 5 months after baseline)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Kasper Søndergaard, PhD, Copenhagen University Hospital - Herlev and Gentofte and Copenhagen University Hospital - Rigshospitalet

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

23 novembre 2026

Completamento primario (Stimato)

1 ottobre 2029

Completamento dello studio (Stimato)

1 aprile 2031

Date di iscrizione allo studio

Primo inviato

14 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

14 novembre 2026

Primo Inserito (Effettivo)

20 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

20 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • STABLE-RCT-2026
  • H-26038898 (Altro identificatore: The Scientific Ethics Committee of the Capital Region of Denmark)
  • p-2026-21537 (Altro identificatore: Research Legal Office, Capital Region of Denmark)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data are not shared publicly, as this is not covered by the ethics and data protection approvals and is restricted by the EU General Data Protection Regulation (GDPR).

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .